Cell culture consumables market seen reaching $25.49 billion by 2030

The Business Research Company says the global cell culture consumables and equipment market will grow from $14.69 billion in 2025 to $16.05 billion in 2026, then reach $25.49 billion by 2030. The report points to cancer research funding, biotech expansion and lab automation as key drivers.

Why it matters: - Cell culture consumables and equipment support drug discovery, tissue engineering, gene therapy, vaccine manufacturing and toxicity testing. - The market’s growth reflects rising demand for the tools that help researchers work with cells in controlled environments. - Advances in this category can speed up research in biotechnology, pharmaceuticals and regenerative medicine.

What happened: - The Business Research Company released a new report on the global cell culture consumables and equipment market on July 30, 2026. - The report estimates the market will grow from $14.69 billion in 2025 to $16.05 billion in 2026. - The report projects the market will reach $25.49 billion by 2030. - The report links the outlook to broader growth in biotechnology and research activity. - A free sample is available here. - The full report is available here.

The details: - The market is forecast to rise at a 9.3% compound annual growth rate from 2025 to 2026. - The report forecasts a 12.3% compound annual growth rate through 2030. - Historical growth has been driven by scarcity of specialized instruments, dependence on traditional culture media, more academic and industrial research, higher vaccine and biologics production, and growing awareness of regenerative medicine. - Future growth is expected to come from bioreactor innovation, automated incubators, investment in stem cell and gene therapy research, expansion of pharmaceutical and biotech sectors, high-throughput screening and smart laboratory tools. - Emerging trends include greater demand for advanced consumables, broader regenerative medicine research, more automation, more drug development use cases and increased focus on premium culture media and reagents. - The report says North America held the largest market share in 2025. - Western Europe ranked second in 2025. - Other regions covered include Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa. - The 2026 report package also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and future trend analysis.

Between the lines: - Rising cancer research funding appears to be a meaningful demand signal for suppliers of cell culture tools and equipment. - The report highlights a shift from basic lab hardware toward automated, higher-value systems and premium consumables. - Regional leadership by North America suggests the strongest concentration of spending and research activity remains in that market.

What's next: - Continued growth will likely depend on how quickly labs adopt automation, high-throughput workflows and next-generation bioprocessing tools. - Pharmaceutical and biotech investment in cell and gene therapies should keep expanding the addressable market. - The report’s forecast implies suppliers with advanced consumables, reagents and smart equipment may capture the fastest growth.

The bottom line: - The cell culture consumables and equipment market is moving from steady expansion to faster growth, with automation, regenerative medicine and research funding driving the next phase.